TT-12

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTT-12
Drug Alias NameHuman papillomavirus specific T cells人乳头瘤病毒特异性T细胞HP-VSTTT12-HP VSTTT-12
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionImmunomodulatorsImmunologic cytotoxicityT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsOropharyngeal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of MedicineTessa Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsOropharyngeal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A